Prevalence, prescriptions, outcomes and costs of type 2 diabetes patients with or without prior coronary artery disease or stroke: a longitudinal 5-year claims-data analysis of over 7 million inhabitants.
Aldo Pietro MaggioniLetizia DondiFelicita AndreottiGiulia RonconiSilvia CalabriaCarlo PiccinniAntonella PedriniImma EspositoNello MartiniPublished in: Therapeutic advances in chronic disease (2021)
The present analysis points to three areas of potential improvement in T2DM management: (a) guideline-recommended treatment patterns of T2DM patients; (b) three-fold recurrences and costs in T2DM patients with, compared to those without, prior cardiovascular events; (c) high event rates associated with chronic CAD and PCI, warranting specific studies aimed at improved prevention.
Keyphrases
- coronary artery disease
- cardiovascular events
- data analysis
- type diabetes
- glycemic control
- percutaneous coronary intervention
- end stage renal disease
- coronary artery bypass grafting
- cardiovascular disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- prognostic factors
- acute myocardial infarction
- weight loss
- brain injury
- aortic valve
- patient reported outcomes
- st elevation myocardial infarction
- drug induced
- acute coronary syndrome
- antiplatelet therapy
- smoking cessation
- cerebral ischemia
- coronary artery bypass